drugset / Trial / NCT05051696
Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to evaluate the effectiveness and safety of oncolytic viruses H101 intra-tumor injection combined with or without radiotherapy in refractory or recurrent gynecological malignancies. And further research the mechanism of oncolytic viruses H101.
Timeline
- Start
- 2021-09-26
- Primary completion
- 2024-03-30
- Completion
- 2025-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | H101 | Other / unclassified | 5e+11 vg | Other |
| Subject | H101 | Other / unclassified | 1e+12 vg | Other |
| Subject | H101 | Other / unclassified | 1.5e+12 vg | Other |